Your account is not claimed yet. You can sign up with ORCID to claim your account.

Gary Gellerman

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Venues

Pharmaceutics

International journal of molecular sciences

Cancers

Chemical biology & drug design

Ariel University Faculty of Natural Sciences

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ariel University Faculty of Natural Sciences

Israel

Dean :: Chemical Sciences

Publications

Olga Semenova, Dmytro Kobzev, Iryna Hovor, Melad Atrash, Faina Nakonechny, Olesia Kulyk, Andrii Bazylevich, Gary Gellerman, Leonid Patsenker
Effect of Solubilizing Group on the Antibacterial Activity of Heptamethine Cyanine Photosensitizers. Pharmaceutics 15 (1) (2023)
Olga Semenova, Dmytro Kobzev, Iryna Hovor, Melad Atrash, Faina Nakonechny, Olesia Kulyk, Andrii Bazylevich, Gary Gellerman, Leonid Patsenker
Effect of Solubilizing Group on the Antibacterial Activity of Heptamethine Cyanine Photosensitizers. Pharmaceutics 15 (1) (2023)
Olga Semenova, Dmytro Kobzev, Iryna Hovor, Melad Atrash, Faina Nakonechny, Olesia Kulyk, Andrii Bazylevich, Gary Gellerman, Leonid Patsenker
Effect of Solubilizing Group on the Antibacterial Activity of Heptamethine Cyanine Photosensitizers. Pharmaceutics 15 (1) (2023)
Olga Semenova, Dmytro Kobzev, Iryna Hovor, Melad Atrash, Faina Nakonechny, Olesia Kulyk, Andrii Bazylevich, Gary Gellerman, Leonid Patsenker
Effect of Solubilizing Group on the Antibacterial Activity of Heptamethine Cyanine Photosensitizers. Pharmaceutics 15 (1) (2023)
Olga Furman, Alisa Zaporozhets, Dror Tobi, Andrii Bazylevich, Michael A Firer, Leonid Patsenker, Gary Gellerman, Bat Chen R Lubin
Novel Cyclic Peptides for Targeting EGFR and EGRvIII Mutation for Drug Delivery. Pharmaceutics 14 (7) (2022)
Bar Levi, Shiri Yacobovich, Michael L Kirby, Maria Becker, Oryan Agranyoni, Boris Redko, Gary Gellerman, Albert Pinhasov, Igor Koman, Elimelech Nesher
Anti-Cancer Effects of Cyclic Peptide ALOS4 in a Human Melanoma Mouse Model. International journal of molecular sciences 22 (17) (2021)
Yosi Gilad, Gary Gellerman, David M Lonard, Bert W O'Malley
Drug Combination in Cancer Treatment-From Cocktails to Conjugated Combinations. Cancers 13 (4) (2021)
Dvir Poplinger, Maksym Bokan, Arkadi Hesin, Ebaston Thankarajan, Helena Tuchinsky, Gary Gellerman, Leonid D Patsenker
Ratiometric Fluorescence Monitoring of Antibody-Guided Drug Delivery to Cancer Cells. Bioconjugate chemistry 32 (8) (2021)
Hodaya Gutman, Andrii Bazylevich, Chandrashekhar Prasad, Ortal Dorfman, Arkadi Hesin, Vered Marks, Leonid D Patsenker, Gary Gellerman
Discovery of Dolastatinol: A Synthetic Analog of Dolastatin 10 and Low Nanomolar Inhibitor of Tubulin Polymerization. ACS medicinal chemistry letters 12 (10) (2021)
Dipak Walunj, Katarina Egarmina, Helena Tuchinsky, Ofer Shpilberg, Oshrat Hershkovitz-Rokah, Flavio Grynszpan, Gary Gellerman
Expedient synthesis and anticancer evaluation of dual-action 9-anilinoacridine methyl triazene chimeras. Chemical biology & drug design 97 (2) (2020)
Faina Nakonechny, Margarita Barel, Arad David, Simor Koretz, Boris Litvak, Elena Ragozin, Ariel Etinger, Oz Livne, Yosef Pinhasi, Gary Gellerman, Marina Nisnevitch
Dark Antibacterial Activity of Rose Bengal. International journal of molecular sciences 20 (13) (2019)

Gary Gellerman.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gary Gellerman